atropine has been researched along with warfarin in 30 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 36,573 | 2,143 | 14,728 |
Protein | Taxonomy | atropine (IC50) | warfarin (IC50) |
---|---|---|---|
Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (30.00) | 18.7374 |
1990's | 1 (3.33) | 18.2507 |
2000's | 9 (30.00) | 29.6817 |
2010's | 11 (36.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bryan, J; Cheung, CY; Haggarty, SJ; Healey, D; Kim, S; Kokel, D; Laggner, C; Macrae, CA; Mateus, R; Peterson, RT; Shoichet, B; Werdich, AA; White, R | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Azuma, H; Fujiwara, M; Hattori, K | 1 |
Crone, HD | 1 |
Altland, K; Goedee, HW | 1 |
Fujiwara, M; Lee, WH | 1 |
Blount, AW; Miller, DS | 1 |
Iwaki, R; Kitagawa, H; Saito, H; Suwa, Y; Yamada, M | 1 |
Schrogie, JJ; Solomon, HM | 1 |
Radić, Z; Taylor, P | 1 |
Chen, X; Luo, Q; Ni, J; Wang, H; Zhang, Q; Zou, H | 1 |
Abbas, S; Bashir, S; Gilani, AH; Khan, A; Mehmood, MH | 1 |
Gilani, AH; Mehmood, MH; Rehman, A; Rehman, NU | 1 |
Borovik, A; Dance, S; Francis, IC; Gupta, R; Ooi, KG; Wang, SB | 1 |
2 review(s) available for atropine and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Genetically dependent variability of drug effects].
Topics: Anemia, Hemolytic; Anesthesia, General; Anesthetics; Animals; Antipyrine; Apnea; Atropine; Body Temperature; Coumarins; Cyanosis; Deficiency Diseases; Dexamethasone; Dogs; Drug Tolerance; Enzymes; Female; Glucosephosphate Dehydrogenase; Humans; Intraocular Pressure; Isonicotinic Acids; Male; Meperidine; Mice; Oxyphenbutazone; Pharmacogenetics; Phenacetin; Phenylbutazone; Phenytoin; Proteins; Rabbits; Rats; Succinylcholine | 1970 |
28 other study(ies) available for atropine and warfarin
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Rapid behavior-based identification of neuroactive small molecules in the zebrafish.
Topics: | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Mechanism of spasmolytic action of 4-methylumbelliferone].
Topics: Ampulla of Vater; Animals; Aorta, Thoracic; Atropine; Catechol O-Methyltransferase Inhibitors; Coumarins; Enzyme Activation; In Vitro Techniques; Liver; Male; Muscle Contraction; Muscle, Smooth; Papaverine; Parasympatholytics; Pyrogallol; Rabbits; Rats | 1973 |
Can allosteric effectors of acetylcholinesterase control the rate of ageing of the phosphonylated enzyme?
Topics: Acetylcholinesterase; Allyl Compounds; Animals; Atropine; Cattle; Coumarins; Erythrocytes; Gallamine Triethiodide; Rabbits; Sarin; Toxiferine; Tropanes; Tubocurarine | 1974 |
Spasmolytic action of 4-methylumbelliferone in isolated guinea-pig's gallbladder.
Topics: Acetylcholine; Animals; Atropine; Barium; Coumarins; Diphenhydramine; Gallbladder; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Papaverine; Parasympatholytics | 1971 |
Atrial fibrillation. II.
Topics: Atrial Fibrillation; Atropine; Digoxin; Electric Countershock; Humans; Male; Middle Aged; Mitral Valve Stenosis; Myocardial Infarction; Ouabain; Warfarin | 1971 |
Quinidine-induced recurrent ventricular fibrillation: (quinidine syncope) treated with transvenous pacemaker.
Topics: Adult; Atrial Fibrillation; Atropine; Blood Cell Count; Chlorpromazine; Coumarins; Creatine Kinase; Digitalis Glycosides; Diuretics; Electric Countershock; Electrocardiography; Female; Heart Valve Prosthesis; Humans; L-Lactate Dehydrogenase; Lactates; Lidocaine; Mitral Valve Stenosis; Pacemaker, Artificial; Paranoid Disorders; Pneumonia; Potassium Chloride; Quinidine; Rheumatic Heart Disease; Syncope; Ventricular Fibrillation | 1971 |
[Studies on new rodenticides of courmarin derivatives. (5). Toxicological studies on T1-coumarin-3-carboxylate].
Topics: Animals; Atropine; Coumarins; Female; In Vitro Techniques; Mice; Pregnancy; Pregnancy, Animal; Rats; Rodenticides | 1965 |
The effect of various drugs on the binding of warfarin-14C to human albumin.
Topics: Atropine; Butyrates; Carbon Isotopes; Phenethylamines; Phenylbutazone; Protein Binding; Serum Albumin; Sulfaphenazole; Thyroxine; Warfarin | 1967 |
The influence of peripheral site ligands on the reaction of symmetric and chiral organophosphates with wildtype and mutant acetylcholinesterases.
Topics: Acetylation; Acetylcholinesterase; Alkaloids; Animals; Atropine; Binding Sites; Cholinesterase Inhibitors; Coumarins; Dichlorvos; Gallamine Triethiodide; Isoquinolines; Kinetics; Ligands; Mice; Mutagenesis, Site-Directed; Organophosphates; Organophosphorus Compounds; Paraoxon; Phosphorylation; Propidium; Stereoisomerism; Umbelliferones | 1999 |
Synthesis and characteristics of the human serum albumin-triazine chiral stationary phase.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Atropine; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fenoprofen; Glutamic Acid; Humans; Ibuprofen; Naproxen; Protein Binding; Serum Albumin; Silicon Dioxide; Spectrophotometry, Ultraviolet; Stereoisomerism; Triazines; Tryptophan; Warfarin | 2000 |
Gastrointestinal stimulant effect of Urginea indica Kunth. and involvement of muscarinic receptors.
Topics: Alkaloids; Animals; Atropine; Calcium Channel Blockers; Cholinergic Agents; Constipation; Coumarins; Dose-Response Relationship, Drug; Drimia; Female; Gastrointestinal Motility; Guinea Pigs; Ileum; Jejunum; Laxatives; Male; Mice; Muscle Contraction; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; Rabbits; Receptors, Muscarinic; Tannins | 2012 |
Studies on prokinetic, laxative and spasmodic activities of Phyllanthus emblica in experimental animals.
Topics: Alkaloids; Animals; Atropine; Constipation; Coumarins; Dyspepsia; Guinea Pigs; Ileum; Jejunum; Laxatives; Mice; Muscle Contraction; Parasympatholytics; Phyllanthus emblica; Plant Extracts; Rabbits; Receptors, Muscarinic; Saponins; Sterols; Tannins; Terpenes | 2013 |
Spontaneous hyphaema secondary to bleeding from an iris vascular tuft in a patient with a supratherapeutic International normalised ratio: case report.
Topics: Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Atropine; Eye Hemorrhage; Female; Glucocorticoids; Hamartoma; Humans; Hyphema; International Normalized Ratio; Iris Diseases; Mydriatics; Ophthalmic Solutions; Prednisolone; Pulmonary Embolism; Warfarin | 2015 |